Jeff Rapp

Title: Jeff Rapp: Innovator in Avian Nucleic Acid Technology

Introduction

Jeff Rapp is a notable inventor based in Athens, GA (US). He has made significant contributions to the field of biotechnology, particularly in avian nucleic acid technology. His work has implications for genetic engineering and transgene expression in avian species.

Latest Patents

Jeff Rapp holds a patent for a groundbreaking invention titled "Chicken ovalbumin nucleotide sequence." This patent provides isolated and recombinant avian nucleic acid molecules that include at least one avian MAR and an avian nucleic acid sequence encoding an ovalbumin transcriptional regulatory region. The isolated nucleic acid is designed to reduce chromosomal positional effects on the transcription of a transgene linked to the ovalbumin transcriptional regulatory region. This innovation is crucial for enhancing the efficiency of transgene expression in recipient avian cells.

Career Highlights

Throughout his career, Jeff Rapp has worked with prominent organizations such as Synageva Biopharma Corporation and the University of Georgia Research Foundation, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.

Collaborations

Some of Jeff Rapp's notable coworkers include Markley C. Leavitt and Robert D. Ivarie. Their collaborative efforts have furthered research and development in avian biotechnology.

Conclusion

Jeff Rapp's innovative work in avian nucleic acid technology exemplifies the impact of biotechnology on genetic engineering. His contributions continue to influence the field and pave the way for future advancements.